tradmap

FATE Earnings FATE THERAPEUTICS INC

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$3 -$1 $0 2020 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $48M $96M 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$282M -$141M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$2 -$1 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Revenue (quarterly)
$0 $3M $7M Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Revenue
Net income (quarterly)
-$52M -$26M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income

Reported EPS history

1–22 of 22
Q2 20262026-06-30-0.512026-08-1310-Q
Q1 20262026-03-31-0.262026-05-1310-Q
FY 20252025-12-31-1.152026-02-2610-K
Q3 20252025-09-30-0.882025-11-1310-Q
Q2 20262025-06-30-0.612026-08-1310-Q
Q1 20262025-03-31-0.322026-05-1310-Q
FY 20252024-12-31-1.642026-02-2610-K
Q3 20252024-09-30-1.192025-11-1310-Q
Q2 20252024-06-30-0.792025-08-1210-Q
Q1 20252024-03-31-0.472025-05-1310-Q
FY 20242023-12-31-1.642025-03-0510-K
Q3 20242023-09-30-1.192024-11-1210-Q
Q2 20242023-06-30-0.732024-08-1310-Q
Q1 20242023-03-31-0.192024-05-0910-Q
FY 20232022-12-31-2.912024-02-2610-K
Q3 20232022-09-30-2.332023-11-0810-Q
Q2 20232022-06-30-1.472023-08-0810-Q
Q1 20232022-03-31-0.682023-05-0310-Q
FY 20222021-12-31-2.242023-02-2810-K
Q3 20222021-09-30-1.522022-11-0310-Q
Q2 20222021-06-30-1.072022-08-0310-Q
FY 20222020-12-31-2.102023-02-2810-K

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.